Key facts
- This page summarizes Michael Rapp's Form 4 filing for Immunome Inc. (IMNM).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Oct 2023, 17:50.
Michael Rapp - 02 Oct 2023 Form 4 Insider Report for Immunome Inc. (IMNM)
- Reporting relationship
- Director
- Issuer ticker
- IMNM
- Reported as of
- 02 Oct 2023
- Net transaction value
- +$1,499,993
- SEC form
- 4
- Accepted by SEC
- 03 Oct 2023, 17:50:48 UTC
- Prior SEC filing
- 12 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/Michael Rapp
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael Rapp filed Form 4 for Immunome Inc. (IMNM) on 03 Oct 2023.
Change
- Previous filing in this sequence was filed on 12 Jun 2023.
- Current net transaction value: +$1,499,993.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IMNM
transaction
Common Stock
Award
- Transaction value
- $1,499,993
- Shares
- +253,806
- Change %
- +31%
- Price
- $5.91
- Shares after
- 1,071,172
- Date
- 02 Oct 2023
- Ownership
- Direct
- Footnotes
- F1
IMNM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 208,742
- Date
- 02 Oct 2023
- Ownership
- See Footnote
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Michael Rapp is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
The shares were issued to the Reporting Person pursuant to the closing of the transactions contemplated by that certain Subscription Agreement, dated as of June 29, 2023, by and among the Reporting Person and the Issuer and in connection with the closing of to the transactions contemplated by that certain Agreement and Plan of Merger and Reorganization, dated as of June 29, 2023, by and among the Issuer, Morphimmune Inc., a Delaware corporation, and Ibiza Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Issuer.
Footnote F2
The shares are held by Broadband Capital Investments LLC ("Broadband"). The reporting person is managing member of Broadband and has voting and investment power with respect to shares held by Broadband.